
PCI Pharma Services Acquires Ajinomoto Althea
PCI Pharma Services has completed its acquisition of Ajinomoto Althea, a CDMO subsidiary of Ajinomoto.
PCI Pharma Services has completed its acquisition of Ajinomoto Althea, a CDMO subsidiary of Ajinomoto.
US-based PCI Pharma Services, a multinational CDMO, is spending $100 million to enhance its capacity and capabilities in aseptic liquid fill-finish and sterile lyophilization at its campus in Bedford, New Hampshire. The move follows the acquisition of Lyophilization Services of New England (LSNE) last December, which added the Bedford site to PCI’s network.